Hologic (HOLX) Competitors $66.33 -1.94 (-2.84%) Closing price 09/19/2025 04:00 PM EasternExtended Trading$66.33 0.00 (-0.01%) As of 09/19/2025 06:35 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock HOLX vs. HQY, HSIC, MASI, MMSI, NEOG, ALC, AMN, AVNS, PEN, and ZBHShould you be buying Hologic stock or one of its competitors? The main competitors of Hologic include HealthEquity (HQY), Henry Schein (HSIC), Masimo (MASI), Merit Medical Systems (MMSI), Neogen (NEOG), Alcon (ALC), AMN Healthcare Services (AMN), AVANOS MEDICAL (AVNS), Penumbra (PEN), and Zimmer Biomet (ZBH). These companies are all part of the "medical" sector. Hologic vs. Its Competitors HealthEquity Henry Schein Masimo Merit Medical Systems Neogen Alcon AMN Healthcare Services AVANOS MEDICAL Penumbra Zimmer Biomet HealthEquity (NASDAQ:HQY) and Hologic (NASDAQ:HOLX) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their risk, dividends, earnings, profitability, valuation, media sentiment, institutional ownership and analyst recommendations. Does the media refer more to HQY or HOLX? In the previous week, Hologic had 22 more articles in the media than HealthEquity. MarketBeat recorded 35 mentions for Hologic and 13 mentions for HealthEquity. HealthEquity's average media sentiment score of 1.56 beat Hologic's score of 0.68 indicating that HealthEquity is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment HealthEquity 11 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Hologic 14 Very Positive mention(s) 1 Positive mention(s) 5 Neutral mention(s) 4 Negative mention(s) 1 Very Negative mention(s) Positive Do insiders and institutionals believe in HQY or HOLX? 99.6% of HealthEquity shares are owned by institutional investors. Comparatively, 94.7% of Hologic shares are owned by institutional investors. 1.5% of HealthEquity shares are owned by insiders. Comparatively, 1.9% of Hologic shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. Which has more volatility and risk, HQY or HOLX? HealthEquity has a beta of 0.5, suggesting that its share price is 50% less volatile than the S&P 500. Comparatively, Hologic has a beta of 0.57, suggesting that its share price is 43% less volatile than the S&P 500. Do analysts rate HQY or HOLX? HealthEquity currently has a consensus target price of $119.77, indicating a potential upside of 27.77%. Hologic has a consensus target price of $79.38, indicating a potential upside of 19.68%. Given HealthEquity's stronger consensus rating and higher possible upside, research analysts plainly believe HealthEquity is more favorable than Hologic.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score HealthEquity 0 Sell rating(s) 1 Hold rating(s) 11 Buy rating(s) 1 Strong Buy rating(s) 3.00Hologic 0 Sell rating(s) 8 Hold rating(s) 8 Buy rating(s) 1 Strong Buy rating(s) 2.59 Is HQY or HOLX more profitable? Hologic has a net margin of 13.79% compared to HealthEquity's net margin of 11.49%. Hologic's return on equity of 19.69% beat HealthEquity's return on equity.Company Net Margins Return on Equity Return on Assets HealthEquity11.49% 12.04% 7.44% Hologic 13.79%19.69%10.82% Which has preferable valuation & earnings, HQY or HOLX? Hologic has higher revenue and earnings than HealthEquity. Hologic is trading at a lower price-to-earnings ratio than HealthEquity, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioHealthEquity$1.20B6.73$96.70M$1.6556.81Hologic$4.03B3.66$789.50M$2.4127.52 SummaryHologic beats HealthEquity on 9 of the 16 factors compared between the two stocks. Get Hologic News Delivered to You Automatically Sign up to receive the latest news and ratings for HOLX and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding HOLX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart HOLX vs. The Competition Export to ExcelMetricHologicMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$14.75B$6.76B$5.78B$10.46BDividend YieldN/A1.21%5.61%4.61%P/E Ratio27.5226.7880.5026.81Price / Sales3.66195.12503.13112.35Price / Cash12.0621.7437.6661.43Price / Book3.004.9815.756.39Net Income$789.50M$178.07M$3.30B$271.80M7 Day Performance2.92%5.36%5.35%3.49%1 Month Performance-3.53%10.93%8.09%9.90%1 Year Performance-18.50%17.52%81.33%28.62% Hologic Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)HOLXHologic4.8334 of 5 stars$66.33-2.8%$79.38+19.7%-19.5%$14.75B$4.03B27.527,063Trending NewsAnalyst ForecastAnalyst RevisionHigh Trading VolumeHQYHealthEquity4.3915 of 5 stars$93.02+0.6%$119.77+28.8%+19.3%$8.01B$1.20B56.383,120Positive NewsHSICHenry Schein3.9125 of 5 stars$68.81-0.3%$76.67+11.4%-6.5%$8.34B$12.77B22.2025,000Positive NewsAnalyst RevisionMASIMasimo4.6739 of 5 stars$145.72-1.2%$194.60+33.5%+25.7%$7.92B$2.15B-17.105,600Analyst DowngradeMMSIMerit Medical Systems4.7624 of 5 stars$82.93-3.0%$107.00+29.0%-16.6%$4.91B$1.43B42.107,400Positive NewsNEOGNeogen3.0973 of 5 stars$5.47-0.5%$7.50+37.1%-68.0%$1.19B$894.66M-1.092,110ALCAlcon3.9175 of 5 stars$77.39-1.1%$96.06+24.1%-21.5%$38.17B$9.91B36.0025,599AMNAMN Healthcare Services4.6445 of 5 stars$18.21-0.2%$23.25+27.7%-59.2%$697.62M$2.98B-2.342,968Positive NewsShort Interest ↓Analyst RevisionAVNSAVANOS MEDICAL1.7465 of 5 stars$12.28+0.5%N/A-51.7%$569.79M$687.80M-1.222,227Positive NewsPENPenumbra4.8606 of 5 stars$263.58-3.4%$302.93+14.9%+27.4%$10.28B$1.28B70.104,500Positive NewsZBHZimmer Biomet4.9082 of 5 stars$100.90-2.1%$111.00+10.0%-5.9%$19.99B$7.83B24.5517,000Trending NewsAnalyst Forecast Related Companies and Tools Related Companies HealthEquity Alternatives Henry Schein Alternatives Masimo Alternatives Merit Medical Systems Alternatives Neogen Alternatives Alcon Alternatives AMN Healthcare Services Alternatives AVANOS MEDICAL Alternatives Penumbra Alternatives Zimmer Biomet Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:HOLX) was last updated on 9/20/2025 by MarketBeat.com Staff From Our PartnersNvidia CEO Makes First Ever Tesla AnnouncementWhile headlines focus on Tesla’s car sales, tech analyst Jeff Brown says the real story is Tesla’s role in a $...Brownstone Research | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredCollege grad makes $64,000 a monthA Wall Street legend just helped train our own proprietary AI system in the stock market (a project that took ...Stansberry Research | SponsoredCrypto Gets Official Government Backing—Here's the WinnerTrump Just Signed the GENIUS Act—One Coin is About to Explode We're at the BEGINNING of smart money really ...Crypto 101 Media | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredNVIDIA's Worst Nightmare?$2 TRILLION Quantum Gold Rush While everyone fights over expensive AI stocks... McKinsey just revealed the ...The Oxford Club | SponsoredTrump’s new nightmare beginsPorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Hologic, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Hologic With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
